Trial Profile
Multicenter, Randomized, Double-Blind, Placebo Controlled Phase IIb Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Stem cell therapies (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors BioStar
- 18 Dec 2016 Status changed from active, no longer recruiting to completed.
- 05 Feb 2016 New trial record